-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.0067.6% Upside
Pacific Biosciences of California, Inc. Frequently Asked Questions
-
What analysts cover Pacific Biosciences of California, Inc.?
Pacific Biosciences of California, Inc. has been rated by research analysts at Jefferies, Morgan Stanley, Piper Sandler, Barclays, Goldman Sachs, Canaccord Genuity in the past 90 days.